ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Olaparib API Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-10G18687
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Olaparib API Market Research Report 2024
BUY CHAPTERS

Global Olaparib API Market Research Report 2026

Code: QYRE-Auto-10G18687
Report
2026-01-23
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Transo-Pharm USA LLC
ALP Pharm Beijing
MSN Laboratories
Alembic Pharmaceuticals
Exelixis Inc
Pfizer Inc
Astrazeneca plc
Novartis
Bayer
Dr. Reddy’s Laboratories
ScinoPham Taiwan
Sun Pharmaceutical Industrial

Olaparib API Market Size

The global Olaparib API market was valued at US$ 1217 million in 2025 and is anticipated to reach US$ 3254 million by 2032, at a CAGR of 15.3% from 2026 to 2032.

Olaparib API Market

Olaparib API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Olaparib API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Olaparib API refers to the active pharmaceutical ingredient (API) in medications containing olaparib, a drug used primarily in cancer treatment. Olaparib is a PARP (poly ADP-ribose polymerase) inhibitor, which works by blocking PARP enzymes involved in DNA repair. This inhibition is particularly effective in cancer cells with BRCA1 or BRCA2 mutations, as these cells rely heavily on PARP for repair. By inhibiting PARP, olaparib causes DNA damage to accumulate in cancer cells, leading to cell death.
The North American market for Olaparib API is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Olaparib API is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Olaparib API include ScinoPham Taiwan, Transo-Pharm USA LLC, ALP Pharm Beijing, MSN Laboratories, Alembic Pharmaceuticals, Exelixis, Pfizer, AstraZeneca, Novartis AG, Bayer AG, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Olaparib API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Olaparib API. The Olaparib API market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Olaparib API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Olaparib API manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Olaparib API Market Report

Report Metric Details
Report Name Olaparib API Market
Accounted market size in 2025 US$ 1217 million
Forecasted market size in 2032 US$ 3254 million
CAGR 15.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Ovarian Cancer
  • Breast Cancer
  • Pancreatic Cancer
  • Prostate Cancer
by Application
  • Pharmaceuticals
  • Biomedical
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ScinoPham Taiwan, Transo-Pharm USA LLC, ALP Pharm Beijing, MSN Laboratories, Alembic Pharmaceuticals, Exelixis, Pfizer, AstraZeneca, Novartis AG, Bayer AG, DR. Reddy's Laboratories, Sun Pharmaceutical Industrial
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Olaparib API manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Olaparib API sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Olaparib API Market growing?

Ans: The Olaparib API Market witnessing a CAGR of 15.3% during the forecast period 2026-2032.

What is the Olaparib API Market size in 2032?

Ans: The Olaparib API Market size in 2032 will be US$ 3254 million.

Who are the main players in the Olaparib API Market report?

Ans: The main players in the Olaparib API Market are ScinoPham Taiwan, Transo-Pharm USA LLC, ALP Pharm Beijing, MSN Laboratories, Alembic Pharmaceuticals, Exelixis, Pfizer, AstraZeneca, Novartis AG, Bayer AG, DR. Reddy's Laboratories, Sun Pharmaceutical Industrial

What are the Application segmentation covered in the Olaparib API Market report?

Ans: The Applications covered in the Olaparib API Market report are Pharmaceuticals, Biomedical, Others

What are the Type segmentation covered in the Olaparib API Market report?

Ans: The Types covered in the Olaparib API Market report are Ovarian Cancer, Breast Cancer, Pancreatic Cancer, Prostate Cancer

1 Olaparib API Market Overview
1.1 Product Definition
1.2 Olaparib API by Type
1.2.1 Global Olaparib API Market Value by Type: 2025 vs 2032
1.2.2 Ovarian Cancer
1.2.3 Breast Cancer
1.2.4 Pancreatic Cancer
1.2.5 Prostate Cancer
1.3 Olaparib API by Application
1.3.1 Global Olaparib API Market Value by Application: 2025 vs 2032
1.3.2 Pharmaceuticals
1.3.3 Biomedical
1.3.4 Others
1.4 Global Olaparib API Market Size Estimates and Forecasts
1.4.1 Global Olaparib API Revenue 2021–2032
1.4.2 Global Olaparib API Sales 2021–2032
1.4.3 Global Olaparib API Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Olaparib API Market Competition by Manufacturers
2.1 Global Olaparib API Sales Market Share by Manufacturers (2021–2026)
2.2 Global Olaparib API Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Olaparib API Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Olaparib API, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Olaparib API, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Olaparib API, Product Types and Applications
2.7 Global Key Manufacturers of Olaparib API, Date of Entry into the Industry
2.8 Global Olaparib API Market Competitive Situation and Trends
2.8.1 Global Olaparib API Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Olaparib API Players Market Share by Revenue
2.8.3 Global Olaparib API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Olaparib API Market Scenario by Region
3.1 Global Olaparib API Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Olaparib API Sales by Region: 2021–2032
3.2.1 Global Olaparib API Sales by Region: 2021–2026
3.2.2 Global Olaparib API Sales by Region: 2027–2032
3.3 Global Olaparib API Revenue by Region: 2021–2032
3.3.1 Global Olaparib API Revenue by Region: 2021–2026
3.3.2 Global Olaparib API Revenue by Region: 2027–2032
3.4 North America Olaparib API Market Facts & Figures by Country
3.4.1 North America Olaparib API Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Olaparib API Sales by Country (2021–2032)
3.4.3 North America Olaparib API Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Olaparib API Market Facts & Figures by Country
3.5.1 Europe Olaparib API Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Olaparib API Sales by Country (2021–2032)
3.5.3 Europe Olaparib API Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Olaparib API Market Facts & Figures by Region
3.6.1 Asia Pacific Olaparib API Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Olaparib API Sales by Region (2021–2032)
3.6.3 Asia Pacific Olaparib API Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Olaparib API Market Facts & Figures by Country
3.7.1 Latin America Olaparib API Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Olaparib API Sales by Country (2021–2032)
3.7.3 Latin America Olaparib API Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Olaparib API Market Facts & Figures by Country
3.8.1 Middle East and Africa Olaparib API Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Olaparib API Sales by Country (2021–2032)
3.8.3 Middle East and Africa Olaparib API Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Olaparib API Sales by Type (2021–2032)
4.1.1 Global Olaparib API Sales by Type (2021–2026)
4.1.2 Global Olaparib API Sales by Type (2027–2032)
4.1.3 Global Olaparib API Sales Market Share by Type (2021–2032)
4.2 Global Olaparib API Revenue by Type (2021–2032)
4.2.1 Global Olaparib API Revenue by Type (2021–2026)
4.2.2 Global Olaparib API Revenue by Type (2027–2032)
4.2.3 Global Olaparib API Revenue Market Share by Type (2021–2032)
4.3 Global Olaparib API Price by Type (2021–2032)
5 Segment by Application
5.1 Global Olaparib API Sales by Application (2021–2032)
5.1.1 Global Olaparib API Sales by Application (2021–2026)
5.1.2 Global Olaparib API Sales by Application (2027–2032)
5.1.3 Global Olaparib API Sales Market Share by Application (2021–2032)
5.2 Global Olaparib API Revenue by Application (2021–2032)
5.2.1 Global Olaparib API Revenue by Application (2021–2026)
5.2.2 Global Olaparib API Revenue by Application (2027–2032)
5.2.3 Global Olaparib API Revenue Market Share by Application (2021–2032)
5.3 Global Olaparib API Price by Application (2021–2032)
6 Key Companies Profiled
6.1 ScinoPham Taiwan
6.1.1 ScinoPham Taiwan Company Information
6.1.2 ScinoPham Taiwan Description and Business Overview
6.1.3 ScinoPham Taiwan Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 ScinoPham Taiwan Olaparib API Product Portfolio
6.1.5 ScinoPham Taiwan Recent Developments/Updates
6.2 Transo-Pharm USA LLC
6.2.1 Transo-Pharm USA LLC Company Information
6.2.2 Transo-Pharm USA LLC Description and Business Overview
6.2.3 Transo-Pharm USA LLC Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Transo-Pharm USA LLC Olaparib API Product Portfolio
6.2.5 Transo-Pharm USA LLC Recent Developments/Updates
6.3 ALP Pharm Beijing
6.3.1 ALP Pharm Beijing Company Information
6.3.2 ALP Pharm Beijing Description and Business Overview
6.3.3 ALP Pharm Beijing Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 ALP Pharm Beijing Olaparib API Product Portfolio
6.3.5 ALP Pharm Beijing Recent Developments/Updates
6.4 MSN Laboratories
6.4.1 MSN Laboratories Company Information
6.4.2 MSN Laboratories Description and Business Overview
6.4.3 MSN Laboratories Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 MSN Laboratories Olaparib API Product Portfolio
6.4.5 MSN Laboratories Recent Developments/Updates
6.5 Alembic Pharmaceuticals
6.5.1 Alembic Pharmaceuticals Company Information
6.5.2 Alembic Pharmaceuticals Description and Business Overview
6.5.3 Alembic Pharmaceuticals Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Alembic Pharmaceuticals Olaparib API Product Portfolio
6.5.5 Alembic Pharmaceuticals Recent Developments/Updates
6.6 Exelixis
6.6.1 Exelixis Company Information
6.6.2 Exelixis Description and Business Overview
6.6.3 Exelixis Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Exelixis Olaparib API Product Portfolio
6.6.5 Exelixis Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Pfizer Olaparib API Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Company Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 AstraZeneca Olaparib API Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Novartis AG
6.9.1 Novartis AG Company Information
6.9.2 Novartis AG Description and Business Overview
6.9.3 Novartis AG Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Novartis AG Olaparib API Product Portfolio
6.9.5 Novartis AG Recent Developments/Updates
6.10 Bayer AG
6.10.1 Bayer AG Company Information
6.10.2 Bayer AG Description and Business Overview
6.10.3 Bayer AG Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Bayer AG Olaparib API Product Portfolio
6.10.5 Bayer AG Recent Developments/Updates
6.11 DR. Reddy's Laboratories
6.11.1 DR. Reddy's Laboratories Company Information
6.11.2 DR. Reddy's Laboratories Description and Business Overview
6.11.3 DR. Reddy's Laboratories Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 DR. Reddy's Laboratories Olaparib API Product Portfolio
6.11.5 DR. Reddy's Laboratories Recent Developments/Updates
6.12 Sun Pharmaceutical Industrial
6.12.1 Sun Pharmaceutical Industrial Company Information
6.12.2 Sun Pharmaceutical Industrial Description and Business Overview
6.12.3 Sun Pharmaceutical Industrial Olaparib API Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sun Pharmaceutical Industrial Olaparib API Product Portfolio
6.12.5 Sun Pharmaceutical Industrial Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Olaparib API Industry Chain Analysis
7.2 Olaparib API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Olaparib API Production Mode & Process Analysis
7.4 Olaparib API Sales and Marketing
7.4.1 Olaparib API Sales Channels
7.4.2 Olaparib API Distributors
7.5 Olaparib API Customer Analysis
8 Olaparib API Market Dynamics
8.1 Olaparib API Industry Trends
8.2 Olaparib API Market Drivers
8.3 Olaparib API Market Challenges
8.4 Olaparib API Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Transo-Pharm USA LLC
ALP Pharm Beijing
MSN Laboratories
Alembic Pharmaceuticals
Exelixis Inc
Pfizer Inc
Astrazeneca plc
Novartis
Bayer
Dr. Reddy’s Laboratories
ScinoPham Taiwan
Sun Pharmaceutical Industrial
List of Tables
 Table 1. Global Olaparib API Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Olaparib API Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Olaparib API Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Olaparib API Sales (kg) of Key Manufacturers (2021–2026)
 Table 5. Global Olaparib API Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Olaparib API Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Olaparib API Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Olaparib API Average Price (US$/g) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Olaparib API, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Olaparib API, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Olaparib API, Product Types and Applications
 Table 12. Global Key Manufacturers of Olaparib API, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Olaparib API Companies by Tier (Tier 1, Tier 2, Tier 3), based on Olaparib API Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Olaparib API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Olaparib API Sales by Region (kg), 2021–2026
 Table 18. Global Olaparib API Sales Market Share by Region (2021–2026)
 Table 19. Global Olaparib API Sales by Region (kg), 2027–2032
 Table 20. Global Olaparib API Sales Market Share by Region (2027–2032)
 Table 21. Global Olaparib API Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Olaparib API Revenue Market Share by Region (2021–2026)
 Table 23. Global Olaparib API Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Olaparib API Revenue Market Share by Region (2027–2032)
 Table 25. North America Olaparib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Olaparib API Sales by Country (kg), 2021–2026
 Table 27. North America Olaparib API Sales by Country (kg), 2027–2032
 Table 28. North America Olaparib API Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Olaparib API Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Olaparib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Olaparib API Sales by Country (kg), 2021–2026
 Table 32. Europe Olaparib API Sales by Country (kg), 2027–2032
 Table 33. Europe Olaparib API Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Olaparib API Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Olaparib API Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Olaparib API Sales by Region (kg), 2021–2026
 Table 37. Asia Pacific Olaparib API Sales by Region (kg), 2027–2032
 Table 38. Asia Pacific Olaparib API Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Olaparib API Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Olaparib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Olaparib API Sales by Country (kg), 2021–2026
 Table 42. Latin America Olaparib API Sales by Country (kg), 2027–2032
 Table 43. Latin America Olaparib API Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Olaparib API Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Olaparib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Olaparib API Sales by Country (kg), 2021–2026
 Table 47. Middle East and Africa Olaparib API Sales by Country (kg), 2027–2032
 Table 48. Middle East and Africa Olaparib API Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Olaparib API Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Olaparib API Sales (kg) by Type (2021–2026)
 Table 51. Global Olaparib API Sales (kg) by Type (2027–2032)
 Table 52. Global Olaparib API Sales Market Share by Type (2021–2026)
 Table 53. Global Olaparib API Sales Market Share by Type (2027–2032)
 Table 54. Global Olaparib API Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Olaparib API Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Olaparib API Revenue Market Share by Type (2021–2026)
 Table 57. Global Olaparib API Revenue Market Share by Type (2027–2032)
 Table 58. Global Olaparib API Price (US$/g) by Type (2021–2026)
 Table 59. Global Olaparib API Price (US$/g) by Type (2027–2032)
 Table 60. Global Olaparib API Sales (kg) by Application (2021–2026)
 Table 61. Global Olaparib API Sales (kg) by Application (2027–2032)
 Table 62. Global Olaparib API Sales Market Share by Application (2021–2026)
 Table 63. Global Olaparib API Sales Market Share by Application (2027–2032)
 Table 64. Global Olaparib API Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Olaparib API Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Olaparib API Revenue Market Share by Application (2021–2026)
 Table 67. Global Olaparib API Revenue Market Share by Application (2027–2032)
 Table 68. Global Olaparib API Price (US$/g) by Application (2021–2026)
 Table 69. Global Olaparib API Price (US$/g) by Application (2027–2032)
 Table 70. ScinoPham Taiwan Company Information
 Table 71. ScinoPham Taiwan Description and Business Overview
 Table 72. ScinoPham Taiwan Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 73. ScinoPham Taiwan Olaparib API Product
 Table 74. ScinoPham Taiwan Recent Developments/Updates
 Table 75. Transo-Pharm USA LLC Company Information
 Table 76. Transo-Pharm USA LLC Description and Business Overview
 Table 77. Transo-Pharm USA LLC Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 78. Transo-Pharm USA LLC Olaparib API Product
 Table 79. Transo-Pharm USA LLC Recent Developments/Updates
 Table 80. ALP Pharm Beijing Company Information
 Table 81. ALP Pharm Beijing Description and Business Overview
 Table 82. ALP Pharm Beijing Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 83. ALP Pharm Beijing Olaparib API Product
 Table 84. ALP Pharm Beijing Recent Developments/Updates
 Table 85. MSN Laboratories Company Information
 Table 86. MSN Laboratories Description and Business Overview
 Table 87. MSN Laboratories Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 88. MSN Laboratories Olaparib API Product
 Table 89. MSN Laboratories Recent Developments/Updates
 Table 90. Alembic Pharmaceuticals Company Information
 Table 91. Alembic Pharmaceuticals Description and Business Overview
 Table 92. Alembic Pharmaceuticals Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 93. Alembic Pharmaceuticals Olaparib API Product
 Table 94. Alembic Pharmaceuticals Recent Developments/Updates
 Table 95. Exelixis Company Information
 Table 96. Exelixis Description and Business Overview
 Table 97. Exelixis Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 98. Exelixis Olaparib API Product
 Table 99. Exelixis Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 103. Pfizer Olaparib API Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. AstraZeneca Company Information
 Table 106. AstraZeneca Description and Business Overview
 Table 107. AstraZeneca Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 108. AstraZeneca Olaparib API Product
 Table 109. AstraZeneca Recent Developments/Updates
 Table 110. Novartis AG Company Information
 Table 111. Novartis AG Description and Business Overview
 Table 112. Novartis AG Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 113. Novartis AG Olaparib API Product
 Table 114. Novartis AG Recent Developments/Updates
 Table 115. Bayer AG Company Information
 Table 116. Bayer AG Description and Business Overview
 Table 117. Bayer AG Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 118. Bayer AG Olaparib API Product
 Table 119. Bayer AG Recent Developments/Updates
 Table 120. DR. Reddy's Laboratories Company Information
 Table 121. DR. Reddy's Laboratories Description and Business Overview
 Table 122. DR. Reddy's Laboratories Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 123. DR. Reddy's Laboratories Olaparib API Product
 Table 124. DR. Reddy's Laboratories Recent Developments/Updates
 Table 125. Sun Pharmaceutical Industrial Company Information
 Table 126. Sun Pharmaceutical Industrial Description and Business Overview
 Table 127. Sun Pharmaceutical Industrial Olaparib API Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 128. Sun Pharmaceutical Industrial Olaparib API Product
 Table 129. Sun Pharmaceutical Industrial Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Olaparib API Distributors List
 Table 133. Olaparib API Customers List
 Table 134. Olaparib API Market Trends
 Table 135. Olaparib API Market Drivers
 Table 136. Olaparib API Market Challenges
 Table 137. Olaparib API Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Olaparib API
 Figure 2. Global Olaparib API Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Olaparib API Market Share by Type: 2025 & 2032
 Figure 4. Ovarian Cancer Product Picture
 Figure 5. Breast Cancer Product Picture
 Figure 6. Pancreatic Cancer Product Picture
 Figure 7. Prostate Cancer Product Picture
 Figure 8. Global Olaparib API Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Olaparib API Market Share by Application: 2025 & 2032
 Figure 10. Pharmaceuticals
 Figure 11. Biomedical
 Figure 12. Others
 Figure 13. Global Olaparib API Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Olaparib API Market Size (US$ Million), 2021–2032
 Figure 15. Global Olaparib API Sales (kg), 2021–2032
 Figure 16. Global Olaparib API Average Price (US$/g), 2021–2032
 Figure 17. Olaparib API Report Years Considered
 Figure 18. Olaparib API Sales Share by Manufacturers in 2025
 Figure 19. Global Olaparib API Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Olaparib API Players: Market Share by Revenue in Olaparib API in 2025
 Figure 21. Olaparib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Olaparib API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Olaparib API Sales Market Share by Country (2021–2032)
 Figure 24. North America Olaparib API Revenue Market Share by Country (2021–2032)
 Figure 25. United States Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Olaparib API Sales Market Share by Country (2021–2032)
 Figure 28. Europe Olaparib API Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Olaparib API Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Olaparib API Revenue Market Share by Region (2021–2032)
 Figure 36. China Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Olaparib API Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Olaparib API Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Olaparib API Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Olaparib API Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Olaparib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Olaparib API by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Olaparib API by Type (2021–2032)
 Figure 56. Global Olaparib API Price (US$/g) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Olaparib API by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Olaparib API by Application (2021–2032)
 Figure 59. Global Olaparib API Price (US$/g) by Application (2021–2032)
 Figure 60. Olaparib API Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Niraparib API Market Research Report 2024
Global PARP Poly ADP Ribose Polymerase Inhibitor Market Research Report 2025
Prostate Cancer PARP Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Niraparib Preparations Market Research Report 2024
Global PARP Poly ADP ribose Polymerase Inhibitors Market Insights Forecast to 2030
Global Oncology API Market Research Report 2024
Global Ceritinib API Market Research Report 2024
PARP Inhibitors for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Drug based on PARP Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Crizotinib API Market Research Report 2024
Global Icotinib API Market Research Report 2024
Global Brigatinib API Market Research Report 2024
Global Poly ADP Ribose Polymerase PARP Inhibitors Market Research Report 2024
Global Olaparib Market Research Report 2024
Global Afatinib API Market Research Report 2024
Global PARP Inhibitors for Breast Cancer Market Research Report 2024
Global Anastrozole APl Market Research Report 2024
Sorafenib Tosylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pazopanib API Market Research Report 2025
Global Oseltamivir Phosphate API Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions